• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer

ww.care

Real Care for Wounded Warriors Foundation Inc.

  • Donate

The new PTSD Family Coach mobile app can help family members of those living with PTSD. owl.li/vWhf300fmEL

May 20, 2016 08:05

The new PTSD Family Coach mobile app can help family members of those living with PTSD. owl.li/vWhf300fmEL

3dd35f07cc91e27c37b183fb9e4e6576_normal.

Nat’l Ctr. for PTSD
@VA_PTSD_Info

The new PTSD Family Coach mobile app can help family members of those living with PTSD. owl.li/vWhf300fmEL

What the New York Times gets wrong about PTSD – Medical Xpress

May 19, 2016 19:24

What the New York Times gets wrong about PTSD – Medical Xpress


Medical Xpress

What the New York Times gets wrong about PTSD
Medical Xpress
With that in mind, Drexel researchers examined how the country’s most influential paper, the New York Times, portrayed posttraumatic stress disorder (PTSD) from the year it was first added to the American Psychiatric Association’s Diagnostic and …

and more »

What the New York Times gets wrong about PTSD – Medical Xpress

May 19, 2016 19:23

What the New York Times gets wrong about PTSD – Medical Xpress


Medical Xpress

What the New York Times gets wrong about PTSD
Medical Xpress
With that in mind, Drexel researchers examined how the country’s most influential paper, the New York Times, portrayed posttraumatic stress disorder (PTSD) from the year it was first added to the American Psychiatric Association’s Diagnostic and …

and more »

Tonix shares soar as PTSD drug shows promise in study – Reuters UK

May 19, 2016 08:06

Tonix shares soar as PTSD drug shows promise in study – Reuters UK


Reuters UK

Tonix shares soar as PTSD drug shows promise in study
Reuters UK
Tonix Pharmaceuticals Holding Corp said a higher dose of its experimental drug for post-traumatic stress disorder (PTSD) helped control symptoms in patients, sending its shares surging 46 percent in premarket trading. A 5.6 mg dose of the drug, TNX-102 …
Tonix Pharma’s PTSD candidate for shows positive effects in mid-stage study; shares up 20% premarketSeeking Alpha
Tonix Pharmaceuticals Reports Positive Topline Results from Phase 2 AtEase Study of TNX-102 SL in Post-Traumatic …GlobeNewswire (press release)
Tonix Pharmaceuticals Phase 2 trial success for military related PTSDProactive Investors USA & Canada

all 6 news articles »

Tonix shares soar as PTSD drug shows promise in study – Reuters UK

May 19, 2016 08:05

Tonix shares soar as PTSD drug shows promise in study – Reuters UK


Reuters UK

Tonix shares soar as PTSD drug shows promise in study
Reuters UK
Tonix Pharmaceuticals Holding Corp said a higher dose of its experimental drug for post-traumatic stress disorder (PTSD) helped control symptoms in patients, sending its shares surging 46 percent in premarket trading. A 5.6 mg dose of the drug, TNX-102 …
Tonix Pharma’s PTSD candidate for shows positive effects in mid-stage study; shares up 20% premarketSeeking Alpha
Tonix Pharmaceuticals Reports Positive Topline Results from Phase 2 AtEase Study of TNX-102 SL in Post-Traumatic …GlobeNewswire (press release)
Tonix Pharmaceuticals Phase 2 trial success for military related PTSDProactive Investors USA & Canada

all 6 news articles »

  • « Previous Page
  • Page 1
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • …
  • Page 52
  • Next Page »

Categories

  • PTSD
  • PTSD Community
  • PTSD Science
  • PTSD Treatment Cure Causes
  • Veterans PTSD

Archives

  • June 2016
  • May 2016
  • April 2016
  • About
  • For Scientists
  • Contact Us

2016-2021 Real Care for Wounded Warriors, A 501(c)3 organization. All donations are tax deductible.